Table 2:
Disease and Strictures Characteristics
| Median age at stricture diagnosis (y, IQR) | 39.0 (30.6–48.9) |
| Median duration after IPAA (y, IQR) | 4.6 (0.2–10.6) |
| Asymptomatic (before dilatation) (n,%) | 9 (45%) |
| Including diversion ileostomy | 5 |
| Symptomatic (before dilatation) (n,%) | 11 (55%) |
| Including obstructive symptoms | 6 |
| Hospitalization for obstructive symptoms | 5 |
| Radiological diagnosis of pouch stricture before endoscopic dilatation (n,%) | 5 (25%) |
| No. of strictures (n) | |
| 1 | 17 (85%) |
| 2 | 3 (15%) |
| Median diameter (mm) | 10 (7.5–11.7) |
| Ulcerated stricture (n,%) | 2 (10%) |
| Stricture location (n,%) | |
| Anastomosis | 20 (87%) |
| Inlet | 2 (8.6%) |
| Afferent limb | 1 (4.3%) |
| Associated lesion of the pouch | |
| Acute pouchitis | 4 (20%) |
| Chronic pouchitis | 5 (25%) |
| Pouch fistula | 4 (20%) |
| Pouch ulceration | 5 (25%) |
| Final stricture diagnosis | |
| Surgery related | 13 (65%) |
| Ischemic | 1 (5%) |
| Crohn’s disease | 6 (30%) |
| IBD related treatment at 1st dilatation | |
| Antibiotics | 6 (30%) |
| Ustekinumab | 1 (5%) |
| Ustekinumab and azathioprine | 1 (5%) |